Publisher
Springer International Publishing
Reference69 articles.
1. McGowan DR, Guy MJ. Time to demand dosimetry for molecular radiotherapy? Br J Radiol. 2015;88(1047):20140720.
2. Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Gleisner K, et al. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy. Eur J Nucl Med Mol Imag. 2014;41(10):1976–88.
3. Fahey F, Zukotynski K, Jadvar H, Capala J. Proceedings of the second NCI–SNMMI workshop on targeted radionuclide therapy. J Nucl Med. 2015;56(7):1119–29.
4. Zukotynski K, Jadvar H, Capala J, Fahey F. Targeted radionuclide therapy: practical applications and future prospects. Biomarkers Cancer. 2016 (5629-BIC-Targeted-Radionuclide-Therapy:-Practical-Applications-and-Future-Prosp.pdf):35–8.
5. Wagner HN, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, et al. Administration guidelines for radioimmunotherapy of non-Hodgkin’s lymphoma with 90Y-labeled anti-CD20 monoclonal antibody. J Nucl Med. 2002;43(2):267–72.